Publications by authors named "N van Pelt"

Metronidazole (2-methyl-5-nitro-1-imidazole-1-ethanol, MNZ) is a well-known and widely used drug for its excellent activity against various anaerobic bacteria and protozoa. The purpose of this study is to elucidate the ability of MNZ to form metal complexes with Cu and Zn and to demonstrate that complexation increases its bioactivity profile against different pathogenic microorganisms. The interaction of MNZ with Cu and Zn was investigated in NaCl aqueous solution under different conditions of temperature (15, 25, and 37 °C) and ionic strength (0.

View Article and Find Full Text PDF

Herein, we report a series of 1,3-diarylpyrazoles that are analogues of compound /HIT 8. We previously identified this molecule as a 'hit' during a high-throughput screening campaign for autophagy inducers. A variety of synthetic strategies were utilized to modify the 1,3-diarylpyrazole core at its 1-, 3-, and 4-position.

View Article and Find Full Text PDF

Several quinoline derivatives incorporating arylnitro and aminochalcone moieties were synthesized and evaluated in vitro against a broad panel of trypanosomatid protozoan parasites responsible for sleeping sickness (Trypanosoma brucei rhodesiense), nagana (Trypanosoma brucei brucei), Chagas disease (Trypanosoma cruzi), and leishmaniasis (Leishmania infantum). Several of the compounds demonstrated significant antiprotozoal activity. Specifically, compounds 2c, 2d, and 4i displayed submicromolar activity against T.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the recovery of cardiac diagnostic procedure volumes in Oceania during the COVID-19 pandemic by comparing data from March 2019, April 2020, and April 2021 across various health facilities.
  • Results showed that 11,902 procedures were performed in April 2021, slightly below pre-pandemic levels, while the rest of the world had similar recovery rates, indicating a small decline in both regions.
  • Although there were no significant differences in overall recovery rates, anatomical coronary testing in Oceania demonstrated poorer recovery compared to the rest of the world, raising concerns about specific diagnostic procedures.
View Article and Find Full Text PDF
Article Synopsis
  • New drugs for treating visceral leishmaniasis are urgently needed, but there haven't been many suitable candidates developed recently.
  • DNDI-6174 is a promising new compound derived from a specific chemical series that shows strong potential against various species of the parasite causing the disease.
  • Preliminary studies on DNDI-6174 indicate it has good safety and effectiveness, making it a viable option for further preclinical development.
View Article and Find Full Text PDF